Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 4NETWORK 3OTHER 2FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Prostate cancer, familial 1

Interventions

enzalutamide 4pembrolizumab 3Docetaxel 3apalutamide 2Testosterone 2Prednisone 2Cholecalciferol 2Celecoxib 2Androgen Antagonists 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2relugolix 1olaparib 1nilutamide 1histrelin 1gallium 68 PSMA-11 1capivasertib 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Yoga 1Triptorelin Pamoate 1Tablets 1Simvastatin 1Sildenafil Citrate 1Pluvicto 1Perioperative Care 1Pentoxifylline 1Methylprednisolone 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Prostatic Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01013129 2021-11-11

Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer

Portland VA Medical Center

Completed
748 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡